This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bonnet D., Dick J.E.: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3, 730–737, doi: 10.1038/nm0797-730.BonnetD.DickJ.E.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNat Med1997373073710.1038/nm0797-7309212098Open DOISearch in Google Scholar
Boughey J.C., Gonzalez R.J., Bonner E., Kuerer H.M.: Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 2007, 12, 1276–1287, doi: 10.1634/theoncologist.12-11-1276.BougheyJ.C.GonzalezR.J.BonnerE.KuererH.M.Current treatment and clinical trial developments for ductal carcinoma in situ of the breastOncologist2007121276128710.1634/theoncologist.12-11-127618055847Open DOISearch in Google Scholar
Caceres S., Pena L., de Andres P.J., Illera M.J., Lopez M.S., Woodward W.A., Reuben J.M., Illera J.C.: Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. PLoS One 2015, 10, e0122277, doi: 10.1371/journal.pone.0122277.CaceresS.PenaL.de AndresP.J.IlleraM.J.LopezM.S.WoodwardW.A.ReubenJ.M.IlleraJ.C.Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366PLoS One201510e012227710.1371/journal.pone.0122277437385825807360Open DOISearch in Google Scholar
Caceres S., Pena L., Lacerda L., Illera M.J., de Andres P.J., Larson R.A., Gao H., Debeb B.G., Woodward W.A., Reuben J.M., Illera J.C.: Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer. Vet Comp Oncol 2017, 15, 980–995, doi: 10.1111/vco.12238.CaceresS.PenaL.LacerdaL.IlleraM.J.de AndresP.J.LarsonR.A.GaoH.DebebB.G.WoodwardW.A.ReubenJ.M.IlleraJ.C.Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancerVet Comp Oncol20171598099510.1111/vco.1223827146723Open DOISearch in Google Scholar
de Mello Souza C.H., Toledo-Piza E., Amorin R., Barboza A., Tobias K.M.: Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009, 50, 506–510.de Mello SouzaC.H.Toledo-PizaE.AmorinR.BarbozaA.TobiasK.M.Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatmentCan Vet J200950506510Search in Google Scholar
Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G.: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1, 555–567, doi: 10.1016/j.stem.2007.08.014.GinestierC.HurM.H.Charafe-JauffretE.MonvilleF.DutcherJ.BrownM.JacquemierJ.ViensP.KleerC.G.LiuS.SchottA.HayesD.BirnbaumD.WichaM.S.DontuG.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell2007155556710.1016/j.stem.2007.08.014242380818371393Open DOISearch in Google Scholar
Hance K.W., Anderson W.F., Devesa S.S., Young H.A., Levine P.H.: Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005, 97, 966–975, doi: 10.1093/jnci/dji172.HanceK.W.AndersonW.F.DevesaS.S.YoungH.A.LevineP.H.Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer InstituteJ Natl Cancer Inst20059796697510.1093/jnci/dji172284493715998949Open DOISearch in Google Scholar
Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., Oshima M., Ikeda T., Asaba R., Yagi H., Masuko T., Shimizu T., Ishikawa T., Kai K., Takahashi E., Imamura Y., Baba Y., Ohmura M., Suematsu M., Baba H., Saya H.: CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011, 19, 387–400, doi: 10.1016/j.ccr.2011.01.038.IshimotoT.NaganoO.YaeT.TamadaM.MotoharaT.OshimaH.OshimaM.IkedaT.AsabaR.YagiH.MasukoT.ShimizuT.IshikawaT.KaiK.TakahashiE.ImamuraY.BabaY.OhmuraM.SuematsuM.BabaH.SayaH.CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthCancer Cell20111938740010.1016/j.ccr.2011.01.03821397861Open DOISearch in Google Scholar
Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., Benson T.J., Evans R.: A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003, 17, 291–297, doi: 10.1111/j.1939-1676.2003.tb02450.x.JergensA.E.SchreinerC.A.FrankD.E.NiyoY.AhrensF.E.EckersallP.D.BensonT.J.EvansR.A scoring index for disease activity in canine inflammatory bowel diseaseJ Vet Intern Med20031729129710.1111/j.1939-1676.2003.tb02450.x12774968Open DOISearch in Google Scholar
Kurebayashi J., Yamamoto S., Otsuki T., Sonoo H.: Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. Br J Cancer 1999, 79, 631–636, doi: 10.1038/sj.bjc.6690099.KurebayashiJ.YamamotoS.OtsukiT.SonooH.Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effectBr J Cancer19997963163610.1038/sj.bjc.6690099236242610027341Open DOISearch in Google Scholar
Marcato P., Dean C.A., Pan D., Araslanova R., Gillis M., Joshi M., Helyer L., Pan L., Leidal A., Gujar S., Giacomantonio C.A., Lee P.W.: Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011, 29, 32–45, doi: 10.1002/stem.563.MarcatoP.DeanC.A.PanD.AraslanovaR.GillisM.JoshiM.HelyerL.PanL.LeidalA.GujarS.GiacomantonioC.A.LeeP.W.Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasisStem Cells201129324510.1002/stem.56321280157Open DOISearch in Google Scholar
Maruo T., Kanemaki N., Onda K., Sato R., Ichihara N., Ochiai H.: Canine amino acid transport system Xc(-): cDNA sequence, distribution and cystine transport activity in lens epithelial cells. J Vet Med Sci 2014, 76, 523–530, doi: 10.1292/jvms.13-0170.MaruoT.KanemakiN.OndaK.SatoR.IchiharaN.OchiaiH.Canine amino acid transport system Xc(-): cDNA sequence, distribution and cystine transport activity in lens epithelial cellsJ Vet Med Sci20147652353010.1292/jvms.13-0170406413624366150Open DOISearch in Google Scholar
Michishita M., Akiyoshi R., Suemizu H., Nakagawa T., Sasaki N., Takemitsu H., Arai T., Takahashi K.: Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Vet J 2012, 193, 508–513, doi: 10.1016/j.tvjl.2012.01.006.MichishitaM.AkiyoshiR.SuemizuH.NakagawaT.SasakiN.TakemitsuH.AraiT.TakahashiK.Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell linesVet J201219350851310.1016/j.tvjl.2012.01.00622326935Open DOISearch in Google Scholar
Michishita M., Akiyoshi R., Yoshimura H., Katsumoto T., Ichikawa H., Ohkusu-Tsukada K., Nakagawa T., Sasaki N., Takahashi K.: Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Res Vet Sci 2011, 91, 254–260, doi: 10.1016/j.rvsc.2010.11.016.MichishitaM.AkiyoshiR.YoshimuraH.KatsumotoT.IchikawaH.Ohkusu-TsukadaK.NakagawaT.SasakiN.TakahashiK.Characterization of spheres derived from canine mammary gland adenocarcinoma cell linesRes Vet Sci20119125426010.1016/j.rvsc.2010.11.01621190702Open DOISearch in Google Scholar
Moreb J.S.: Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008, 3, 237–246, doi: 10.2174/ 157488808786734006.MorebJ.S.Aldehyde dehydrogenase as a marker for stem cellsCurr Stem Cell Res Ther2008323724610.2174/15748880878673400619075754Open DOISearch in Google Scholar
Mu Z., Klinowska T., Dong X., Foster E., Womack C., Fernandez S.V., Cristofanilli M.: AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. J Exp Clin Cancer Res 2014, 33, 47, doi: 10.1186/1756-9966-33-47.MuZ.KlinowskaT.DongX.FosterE.WomackC.FernandezS.V.CristofanilliM.AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsJ Exp Clin Cancer Res2014334710.1186/1756-9966-33-47406151324886365Open DOISearch in Google Scholar
Nishikawa S., Konno M., Hamabe A., Hasegawa S., Kano Y., Ohta K., Fukusumi T., Sakai D., Kudo T., Haraguchi N., Satoh T., Takiguchi S., Mori M., Doki Y., Ishii H.: Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Int J Oncol 2013, 42, 1437–1442, doi: 10.3892/ijo.2013.1837.NishikawaS.KonnoM.HamabeA.HasegawaS.KanoY.OhtaK.FukusumiT.SakaiD.KudoT.HaraguchiN.SatohT.TakiguchiS.MoriM.DokiY.IshiiH.Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapyInt J Oncol2013421437144210.3892/ijo.2013.183723440340Open DOISearch in Google Scholar
Okazaki S., Shintani S., Hirata Y., Suina K., Semba T., Yamasaki J., Umene K., Ishikawa M., Saya H., Nagano O.: Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells. Oncotarget 2018, 9, 33832–33843, doi: 10.18632/oncotarget.26112.OkazakiS.ShintaniS.HirataY.SuinaK.SembaT.YamasakiJ.UmeneK.IshikawaM.SayaH.NaganoO.Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cellsOncotarget20189338323384310.18632/oncotarget.26112617346830333913Open DOISearch in Google Scholar
Otsubo K., Nosaki K., Imamura C.K., Ogata H., Fujita A., Sakata S., Hirai F., Toyokawa G., Iwama E., Harada T., Seto T., Takenoyama M., Ozeki T., Mushiroda T., Inada M., Kishimoto J., Tsuchihashi K., Suina K., Nagano O., Saya H., Nakanishi Y., Okamoto I.: Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer. Cancer Sci 2017, 108, 1843–1849, doi: 10.1111/cas.13309.OtsuboK.NosakiK.ImamuraC.K.OgataH.FujitaA.SakataS.HiraiF.ToyokawaG.IwamaE.HaradaT.SetoT.TakenoyamaM.OzekiT.MushirodaT.InadaM.KishimotoJ.TsuchihashiK.SuinaK.NaganoO.SayaH.NakanishiY.OkamotoI.Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancerCancer Sci20171081843184910.1111/cas.13309558151628667792Open DOISearch in Google Scholar
Perez Alenza M.D., Tabanera E., Pena L.: Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am Vet Med Assoc 2001, 219, 1110–1114, doi: 10.2460/javma.2001.219.1110.PerezAlenza M.D.TabaneraE.PenaL.Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999)J Am Vet Med Assoc20012191110111410.2460/javma.2001.219.111011700710Open DOISearch in Google Scholar
Reya T., Morrison S.J., Clarke M.F., Weissman I.L.: Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105–111, doi: 10.1038/35102167.ReyaT.MorrisonS.J.ClarkeM.F.WeissmanI.L.Stem cells, cancer, and cancer stem cellsNature200141410511110.1038/3510216711689955Open DOISearch in Google Scholar
Ruiu R., Rolih V., Bolli E., Barutello G., Riccardo F., Quaglino E., Merighi I.F., Pericle F., Donofrio G., Cavallo F., Conti L.: Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter. Cancer Immunol Immunother 2019, 68, 131–141, doi: 10.1007/s00262-018-2185-1.RuiuR.RolihV.BolliE.BarutelloG.RiccardoF.QuaglinoE.MerighiI.F.PericleF.DonofrioG.CavalloF.ContiL.Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporterCancer Immunol Immunother20196813114110.1007/s00262-018-2185-129947961Open DOISearch in Google Scholar
Sharma M.K., Seidlitz E.P., Singh G.: Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun 2010, 391, 91–95, doi: 10.1016/j.bbrc.2009.10.168.SharmaM.K.SeidlitzE.P.SinghG.Cancer cells release glutamate via the cystine/glutamate antiporterBiochem Biophys Res Commun2010391919510.1016/j.bbrc.2009.10.16819896463Open DOISearch in Google Scholar
Shirakawa K., Tsuda H., Heike Y., Kato K., Asada R., Inomata M., Sasaki H., Kasumi F., Yoshimoto M., Iwanaga T., Konishi F., Terada M., Wakasugi H.: Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 2001, 61, 445–451.ShirakawaK.TsudaH.HeikeY.KatoK.AsadaR.InomataM.SasakiH.KasumiF.YoshimotoM.IwanagaT.KonishiF.TeradaM.WakasugiH.Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancerCancer Res200161445451Search in Google Scholar
Sun S., Wang Z.: ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Biochem Biophys Res Commun 2010, 396, 843–848, doi: 10.1016/j.bbrc.2010.04.170.SunS.WangZ.ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasisBiochem Biophys Res Commun201039684384810.1016/j.bbrc.2010.04.17020450887Open DOISearch in Google Scholar
Tanabe A., Kimura K., Tazawa H., Maruo T., Taguchi M., Sahara H.: Functional analysis of CD44 variants and xCT in canine tumours. Vet Med Sci 2021, 7, 577–585, doi: 10.1002/vms3.397.TanabeA.KimuraK.TazawaH.MaruoT.TaguchiM.SaharaH.Functional analysis of CD44 variants and xCT in canine tumoursVet Med Sci2021757758510.1002/vms3.397802562333210459Open DOISearch in Google Scholar
Timmerman L.A., Holton T., Yuneva M., Louie R.J., Padro M., Daemen A., Hu M., Chan D.A., Ethier S.P., van ’t Veer L.J., Polyak K., McCormick F., Gray J.W.: Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 2013, 24, 450–465, doi: 10.1016/j.ccr.2013.08.020.TimmermanL.A.HoltonT.YunevaM.LouieR.J.PadroM.DaemenA.HuM.ChanD.A.EthierS.P.van ’tVeer L.J.PolyakK.McCormickF.GrayJ.W.Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic targetCancer Cell20132445046510.1016/j.ccr.2013.08.020393131024094812Open DOISearch in Google Scholar
Uyama R., Nakagawa T., Hong S.H., Mochizuki M., Nishimura R., Sasaki N.: Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression. Vet Comp Oncol 2006, 4, 104–113, doi: 10.1111/j.1476-5810.2006.00098.x.UyamaR.NakagawaT.HongS.H.MochizukiM.NishimuraR.SasakiN.Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expressionVet Comp Oncol2006410411310.1111/j.1476-5810.2006.00098.x19754820Open DOISearch in Google Scholar
Van den Eynden G.G., Van Laere S.J., Van der Auwera I., Merajver S.D., Van Marck E.A., van Dam P., Vermeulen P.B., Dirix L.Y., van Golen K.L.: Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 2006, 95, 219–228, doi: 10.1007/s10549-005-9002-1.Vanden Eynden G.G.VanLaere S.J.Vander Auwera I.MerajverS.D.VanMarck E.A.van DamP.VermeulenP.B.DirixL.Y.van GolenK.L.Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancerBreast Cancer Res Treat20069521922810.1007/s10549-005-9002-116244790Open DOISearch in Google Scholar
Vassalli G.: Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells. Stem Cells Int 2019, 2019, 3904645, doi: 10.1155/2019/3904645.VassalliG.Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem CellsStem Cells Int20192019390464510.1155/2019/3904645634881430733805Open DOISearch in Google Scholar
Visvader J.E., Stingl J.: Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev 2014, 28, 1143–1158, doi: 10.1101/gad.242511.114.VisvaderJ.E.StinglJ.Mammary stem cells and the differentiation hierarchy: current status and perspectivesGenes Dev2014281143115810.1101/gad.242511.114405276124888586Open DOISearch in Google Scholar
Xiao Y., Ye Y., Yearsley K., Jones S., Barsky S.H.: The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 2008, 173, 561–574, doi: 10.2353/ajpath.2008.071214.XiaoY.YeY.YearsleyK.JonesS.BarskyS.H.The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotypeAm J Pathol200817356157410.2353/ajpath.2008.071214247579218599608Open DOISearch in Google Scholar
Yae T., Tsuchihashi K., Ishimoto T., Motohara T., Yoshikawa M., Yoshida G.J., Wada T., Masuko T., Mogushi K., Tanaka H., Osawa T., Kanki Y., Minami T., Aburatani H., Ohmura M., Kubo A., Suematsu M., Takahashi K., Saya H., Nagano O.: Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun 2012, 3, 883, doi: 10.1038/ncomms1892.YaeT.TsuchihashiK.IshimotoT.MotoharaT.YoshikawaM.YoshidaG.J.WadaT.MasukoT.MogushiK.TanakaH.OsawaT.KankiY.MinamiT.AburataniH.OhmuraM.KuboA.SuematsuM.TakahashiK.SayaH.NaganoO.Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cellNat Commun2012388310.1038/ncomms189222673910Open DOISearch in Google Scholar
Yamauchi H., Woodward W.A., Valero V., Alvarez R.H., Lucci A., Buchholz T.A., Iwamoto T., Krishnamurthy S., Yang W., Reuben J.M., Hortobagyi G.N., Ueno N.T.: Inflammatory breast cancer: what we know and what we need to learn. Oncologist 2012, 17, 891–899, doi: 10.1634/theoncologist.2012-0039.YamauchiH.WoodwardW.A.ValeroV.AlvarezR.H.LucciA.BuchholzT.A.IwamotoT.KrishnamurthyS.YangW.ReubenJ.M.HortobagyiG.N.UenoN.T.Inflammatory breast cancer: what we know and what we need to learnOncologist20121789189910.1634/theoncologist.2012-0039339964322584436Open DOISearch in Google Scholar
Zhou Y., Yang J., Chen C., Li Z., Chen Y., Zhang X., Wang L., Zhou J.: Polyphyllin -Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT. Front Pharmacol 2021, 12, 670224, doi: 10.3389/fphar.2021.670224.ZhouY.YangJ.ChenC.LiZ.ChenY.ZhangX.WangL.ZhouJ.Polyphyllin -Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCTFront Pharmacol20211267022410.3389/fphar.2021.670224814181834040532Open DOISearch in Google Scholar